4.6 Article

A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas

Eriel Sandika Pareira et al.

Summary: The relevance of oligodendroglial histological features to patient prognoses is controversial. This study reveals the correlation between oligodendroglioma diagnosis, chromosomal/genetic characteristics, and patient survival.

BRAIN TUMOR PATHOLOGY (2022)

Article Cell Biology

ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer

Harun Ozturk et al.

Summary: This study identifies ISL2 as a putative tumor suppressor in pancreatic ductal adenocarcinoma (PDA). ISL2 is epigenetically silenced and its reduced expression correlates with poor patient survival. ISL2 regulates the expression of metabolic genes and its depletion increases oxidative phosphorylation (OXPHOS). Spatial transcriptomic analysis shows heterogeneous intratumoral ISL2 expression, which correlates with the expression of critical metabolic genes.

DEVELOPMENTAL CELL (2022)

Article Computer Science, Interdisciplinary Applications

Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis

Richard J. Chen et al.

Summary: This study proposes an interpretable strategy for multimodal fusion of histology image and genomic features for survival outcome prediction. The results on glioma and clear cell renal cell carcinoma datasets demonstrate that this approach improves the prognostic determinations.

IEEE TRANSACTIONS ON MEDICAL IMAGING (2022)

Article Clinical Neurology

FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway

Liang Guo et al.

Summary: NUF2 protein is highly expressed in glioma and plays a regulatory role in glioma TMZ resistance. Knockdown of NUF2 attenuates the malignant phenotypes of TMZ-resistant cells and inhibits tumor growth. The transcription factor FOXM1 interacts with NUF2 to regulate the effects of TMZ on glioma cell proliferation, apoptosis, and autophagy.

NEUROPATHOLOGY (2022)

Article Oncology

CODEL: phase III study of RT, RT plus TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Kurt A. Jaeckle et al.

Summary: The study demonstrated that patients treated with temozolomide alone had significantly shorter progression-free survival (PFS) compared to those receiving radiotherapy. Patients not receiving radiotherapy also had shorter PFS, but there was no significant difference in overall survival. There were no significant differences between groups in terms of adverse events and neurocognitive decline.

NEURO-ONCOLOGY (2021)

Article Genetics & Heredity

Chinese Glioma Genome Atlas (CGGA) : A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients

Zheng Zhao et al.

Summary: The Chinese Glioma Genome Atlas (CGGA) is a user-friendly data portal for the storage and interactive exploration of cross-omics data related to gliomas. It provides researchers with rapid and convenient access to high-quality functional genomic data resources for biological studies and clinical applications.

GENOMICS PROTEOMICS & BIOINFORMATICS (2021)

Article Oncology

Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses

Zijiang Yang et al.

Summary: Through large-scale sample studies, key factors, mechanisms, and potential biomarkers related to the occurrence and progression of gliomas have been revealed, providing a foundation for further in-depth research.

FRONTIERS IN ONCOLOGY (2021)

Article Clinical Neurology

Clinical Characteristics and Overall Survival Prognostic Nomogram for Oligodendroglioma: A Surveillance, Epidemiology, and End Results Population-Based Analysis

Liang Cao et al.

Summary: This study investigated demographics, outcomes, and prognostic factors of patients with oligodendroglioma, developing a clinical prognosis model to predict survival time. Different grade oligodendrogliomas exhibited varying survival times and influencing factors, with a constructed nomogram showing good predictive performance.

WORLD NEUROSURGERY (2021)

Article Neurosciences

TROAP regulates cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells

Zong-qing Zhao et al.

Summary: The study demonstrated that TROAP plays an oncogenic role in glioma by activating the Wnt/beta-Catenin signaling pathway, leading to cell proliferation, migration, invasion, and poor prognosis. Inhibition of TROAP or downstream targets of Wnt/beta-Catenin pathway could reverse the tumor-promoting effects, suggesting TROAP as a potential novel target for glioma therapy.

CNS NEUROSCIENCE & THERAPEUTICS (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Review Oncology

APLN/APLNR Signaling Controls Key Pathological Parameters of Glioblastoma

Roland E. Kaelin et al.

Summary: The upregulation of Apelin and its receptor in glioblastoma plays a crucial role in tumor progression by promoting angiogenesis and tumor cell invasiveness. Targeting APLN/APLNR signaling shows promise for anti-angiogenic and anti-invasive therapy, potentially improving outcomes for patients with GBM.

CANCERS (2021)

Article Medicine, General & Internal

A rare form of ion channel gene mutation identified as underlying cause of generalized epilepsy

Till Agnes et al.

ORVOSI HETILAP (2019)

Article Multidisciplinary Sciences

Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas

Zheng Zhao et al.

SCIENTIFIC DATA (2017)

Review Clinical Neurology

Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis

Shigeo Ohba et al.

NEUROLOGIA MEDICO-CHIRURGICA (2016)

Article Clinical Neurology

Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma

Kazuhiro Tanaka et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2015)

Article Multidisciplinary Sciences

Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures

Tommy Stodberg et al.

NATURE COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy

Kristopher T. Kahle et al.

EMBO REPORTS (2014)

Article Biochemistry & Molecular Biology

RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas

Zhao-Shi Bao et al.

GENOME RESEARCH (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Oncology

Survival and long-term health and cognitive outcomes after low-grade glioma

Gregory T. Armstrong et al.

NEURO-ONCOLOGY (2011)

Article Mathematical & Computational Biology

Selection of important variables and determination of functional form for continuous predictors in multivariable model building

Willi Sauerbrei et al.

STATISTICS IN MEDICINE (2007)